Advertisement

Ads Placeholder
Loading...

Epigenomics AG

EPGNY•PNK
Healthcare
Medical - Diagnostics & Research
$2.39
$0.00(0.00%)
U.S. Market opens in 58h 1m

Epigenomics AG (EPGNY) Stock Overview

Explore Epigenomics AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-0.48
EPS (TTM)$-1.49
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

EPGNY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Epigenomics AG (EPGNY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.48 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-0.00%
6-Month Change
-14.64%
Year-to-Date (YTD) Change
N/A
1-Year Change
-18.43%
3-Year Change
-96.04%
5-Year Change
-98.77%
All-Time (Max) Change
-99.32%

Contact Information

https://www.epigenomics.com
49 30 243 450
Geneststrasse 5, Berlin, NaN, 10829

Company Facts

330 Employees
IPO DateJul 10, 2013
CountryDE

Frequently Asked Questions